Aliases & Classifications for Fibromatosis

MalaCards integrated aliases for Fibromatosis:

Name: Fibromatosis 53 55 73

Classifications:



External Ids:

UMLS 73 C0016048

Summaries for Fibromatosis

NIH Rare Diseases : 53 Fibromatosis refers to a group of conditions characterized by overgrowths of skin and connective tissue called fibromas. These fibromas are usually benign (non-cancerous). Fibromatosis can be classified by a person's age or by the location of the fibromas. The cause of fibromatosis is often unknown, and treatment depends on the individual disease.

MalaCards based summary : Fibromatosis is related to desmoid disease, hereditary and infantile digital fibromatosis. An important gene associated with Fibromatosis is SOS1 (SOS Ras/Rac Guanine Nucleotide Exchange Factor 1), and among its related pathways/superpathways are Nanog in Mammalian ESC Pluripotency and PI3K-Akt signaling pathway. The drugs Sorafenib and Folic Acid have been mentioned in the context of this disorder. Affiliated tissues include breast, skin and bone, and related phenotypes are cardiovascular system and cellular

Wikipedia : 76 The term fibromatosis refers to a group of soft tissue tumors which have certain characteristics in... more...

Related Diseases for Fibromatosis

Diseases related to Fibromatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 233)
# Related Disease Score Top Affiliating Genes
1 desmoid disease, hereditary 33.7 APC CTNNB1
2 infantile digital fibromatosis 33.6 DES VIM
3 desmoid tumor 32.5 APC CTNNB1 KIT
4 pseudosarcomatous fibromatosis 31.7 ACTC1 CTNNB1 DES VIM
5 infantile myofibromatosis 30.7 ACTC1 DES VIM
6 familial adenomatous polyposis 1 30.5 APC CTNNB1
7 gingival hypertrophy 29.9 ANTXR2 VIM
8 benign breast phyllodes tumor 29.8 KIT VIM
9 fibroblastic rheumatism 29.4 ACTC1 DES
10 non-langerhans-cell histiocytosis 29.0 ACTC1 DES
11 fasciitis 28.8 ACTC1 DES VIM
12 dendritic cell tumor 28.7 ACTC1 VIM
13 spindle cell carcinoma 28.7 ACTC1 DES VIM
14 glomus tumor 28.1 ACTC1 DES VIM
15 malignant fibroxanthoma 28.1 ACTC1 DES VIM
16 fibrous histiocytoma 28.1 ACTC1 DES VIM
17 gastrointestinal stromal tumor 28.0 ACTC1 DES KIT VIM
18 rhabdomyosarcoma 27.8 ACTC1 DES VIM
19 inflammatory myofibroblastic tumor 27.3 ACTC1 DES KIT VIM
20 leiomyoma 27.2 ACTC1 DES KIT VIM
21 hyaline fibromatosis syndrome 12.4
22 fibromatosis, gingival, 1 12.4
23 fibromatosis, gingival, with progressive deafness 12.3
24 fibromatosis, gingival, 2 12.2
25 fibromatosis, gingival, 4 12.2
26 fibromatosis, gingival, 5 12.2
27 gingival fibromatosis 12.2
28 plantar fascial fibromatosis 12.0
29 fibromatosis, gingival, with distinctive facies 12.0
30 hypertrichosis, congenital generalized, with or without gingival hyperplasia 12.0
31 fibromatosis, gingival, 3 12.0
32 zimmermann-laband syndrome 1 11.9
33 ledderhose disease 11.9
34 myofibromatosis, infantile, 1 11.9
35 fibromatosis, gingival, with hypertrichosis and mental retardation 11.8
36 fibromatosis multiple non ossifying 11.8
37 dupuytren contracture 11.8
38 ramon syndrome 11.4
39 peritonitis 11.3
40 amelogenesis imperfecta, type ig 11.2
41 zimmermann-laband syndrome 11.1
42 congenital torticollis 11.1
43 rutherfurd syndrome 10.8
44 oculocerebral syndrome with hypopigmentation 10.8
45 zimmermann-laband syndrome 2 10.8
46 peyronie's disease 10.8
47 hyalinosis, inherited systemic 10.8
48 calcifying aponeurotic fibroma 10.8
49 gingivitis 10.7
50 hepatic adenomas, familial 10.6 APC CTNNB1

Graphical network of the top 20 diseases related to Fibromatosis:



Diseases related to Fibromatosis

Symptoms & Phenotypes for Fibromatosis

MGI Mouse Phenotypes related to Fibromatosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.09 ACTC1 KIT ANTXR2 REST APC SOS1
2 cellular MP:0005384 10.06 DES ACTC1 KIT ANTXR2 REST APC
3 mortality/aging MP:0010768 9.97 DES ACTC1 KIT ANTXR2 REST APC
4 embryo MP:0005380 9.85 VIM KIT REST APC SOS1 CTNNB1
5 muscle MP:0005369 9.8 DES ACTC1 KIT APC SOS1 CTNNB1
6 no phenotypic analysis MP:0003012 9.55 KIT ANTXR2 APC SOS1 CTNNB1
7 reproductive system MP:0005389 9.43 KIT ANTXR2 REST APC CTNNB1 VIM
8 vision/eye MP:0005391 9.1 KIT REST APC SOS1 CTNNB1 VIM

Drugs & Therapeutics for Fibromatosis

Drugs for Fibromatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
2
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
3
Nicotinamide Approved, Investigational, Nutraceutical Phase 3 98-92-0 936
4
Niacin Approved, Investigational, Nutraceutical Phase 3 59-67-6 938
5 Vitamin B Complex Phase 3,Phase 2
6 Protein Kinase Inhibitors Phase 3,Phase 2,Phase 1
7 Micronutrients Phase 3
8 Nicotinic Acids Phase 3
9 Trace Elements Phase 3
10 Vitamins Phase 3
11 Folate Nutraceutical Phase 3,Phase 2
12 Vitamin B9 Nutraceutical Phase 3,Phase 2
13 Vitamin B3 Nutraceutical Phase 3
14
Toremifene Approved, Investigational Phase 2 89778-26-7 3005573
15
Vinblastine Approved Phase 2 865-21-4 13342 241903
16
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
17
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
18
Aminolevulinic acid Approved Phase 2 106-60-5 137
19
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
20
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177
21
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
22
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 5284616 6436030 46835353
23
nivolumab Approved Phase 2 946414-94-4
24
Tamoxifen Approved Phase 2,Phase 1 10540-29-1 2733526
25
Sulindac Approved, Investigational Phase 2 38194-50-2 5352 1548887
26
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
27
Citric Acid Approved, Nutraceutical, Vet_approved Phase 2 77-92-9 311
28 Selective Estrogen Receptor Modulators Phase 2,Phase 1
29 Hormone Antagonists Phase 2,Phase 1,Early Phase 1
30 Hormones Phase 2,Phase 1,Early Phase 1
31 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2,Phase 1,Early Phase 1
32 Estrogen Receptor Modulators Phase 2,Phase 1
33 Estrogens Phase 2,Phase 1,Early Phase 1
34 Bone Density Conservation Agents Phase 2,Phase 1
35 Antineoplastic Agents, Hormonal Phase 2,Phase 1
36 Imatinib Mesylate Phase 2,Phase 1 220127-57-1 123596
37 Folic Acid Antagonists Phase 2
38 Dermatologic Agents Phase 2
39 Nucleic Acid Synthesis Inhibitors Phase 2
40 Angiogenesis Inhibitors Phase 2
41 Angiogenesis Modulating Agents Phase 2
42 Immunosuppressive Agents Phase 2,Phase 1
43 Antirheumatic Agents Phase 2
44 Antimetabolites Phase 2
45 Antimetabolites, Antineoplastic Phase 2
46 Antimitotic Agents Phase 2
47 Calcium, Dietary Phase 2
48 Antineoplastic Agents, Phytogenic Phase 2
49 Albumin-Bound Paclitaxel Phase 2
50 Anesthetics Phase 2

Interventional clinical trials:

(show all 40)
# Name Status NCT ID Phase Drugs
1 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
2 Ledderhose Disease: Radiotherapy or Not? Recruiting NCT03507010 Phase 3
3 Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Active, not recruiting NCT02066181 Phase 3 Sorafenib Tosylate
4 Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Unknown status NCT02353429 Phase 2 Toremifene
5 Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010) Unknown status NCT01184586 Phase 2
6 A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) Completed NCT02495519 Phase 2 Imatinib
7 Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis Completed NCT00287846 Phase 1, Phase 2 imatinib mesylate
8 Radiation Therapy in Treating Patients With Aggressive Fibromatoses Completed NCT00030680 Phase 2
9 Study to Evaluate Imatinib in Desmoid Tumors Completed NCT01137916 Phase 2 Imatinib
10 Vinblastine and Methotrexate in Treating Children With Desmoid Tumors Completed NCT00003019 Phase 2 methotrexate;vinblastine sulfate
11 Toremifene in Treating Patients With Desmoid Tumors Completed NCT00002595 Phase 2 toremifene
12 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2 Imatinib mesylate
13 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
14 A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Recruiting NCT01265030 Phase 1, Phase 2 Sirolimus
15 Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors Recruiting NCT01898416 Phase 2 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
16 PAZOPANIB Efficacy and Tolerance in Desmoids Tumors Recruiting NCT01876082 Phase 2 PAZOPANIB treatment;Active Comparator: Vinblastine and Methotrexate
17 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
18 Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma Recruiting NCT03275818 Phase 2 nab paclitaxel
19 Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies Recruiting NCT03422679 Phase 1, Phase 2 CB-103
20 Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis Active, not recruiting NCT01981551 Phase 2 PF-03084014
21 Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor Active, not recruiting NCT00068419 Phase 2 tamoxifen citrate;sulindac
22 Imatinib in Patients With Desmoid Tumor and Chondrosarcoma Active, not recruiting NCT00928525 Phase 2 Imatinib Mesylate
23 Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors Withdrawn NCT00978146 Phase 2 Hydroxyurea
24 MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors Recruiting NCT02076906 Phase 1
25 Endoxifen in Adults With Hormone Receptor Positive Solid Tumors Active, not recruiting NCT01273168 Phase 1 Z-Endoxifen
26 Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 Not yet recruiting NCT03459469 Phase 1 Tegavivint
27 Peripheral Primitive Fibromatosis Unknown status NCT01801176 Not Applicable
28 Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients Unknown status NCT02547831
29 Knee Stiffness in Fibrosis Diathesis Unknown status NCT02294890
30 Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth Completed NCT00104026
31 Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment Completed NCT02476305 Not Applicable
32 A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome Completed NCT01286662
33 Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas Completed NCT01567046
34 National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) Recruiting NCT02867033 Not Applicable
35 BioHFS - Biomarker for Hyaline Fibromatosis Syndrome Recruiting NCT03196115
36 Optional Sub-study to Intraoperative Imaging With ICG Registry Recruiting NCT02651246
37 18F-FES PET/CT in Imaging Patients With Desmoid Tumors Active, not recruiting NCT02374931 Early Phase 1 F-18 16 Alpha-Fluoroestradiol
38 Natural Disease Progress of Dupuytren Disease Active, not recruiting NCT01923103
39 Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Active, not recruiting NCT00919269
40 Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies No longer available NCT02955446 PF-03084014

Search NIH Clinical Center for Fibromatosis

Genetic Tests for Fibromatosis

Anatomical Context for Fibromatosis

MalaCards organs/tissues related to Fibromatosis:

41
Breast, Skin, Bone, Bone Marrow, Colon, Tongue, Thyroid

Publications for Fibromatosis

Articles related to Fibromatosis:

(show top 50) (show all 904)
# Title Authors Year
1
Optimal management of desmoid fibromatosis. ( 29926797 )
2018
2
Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-I^1 (TGF-I^1). ( 29944666 )
2018
3
Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS). ( 29316163 )
2018
4
Optimal radiotherapy strategy for primary or recurrent fibromatosis and long-term results. ( 29813130 )
2018
5
Unexpected Hydronephrosis: Mesenteric Fibromatosis. ( 29730360 )
2018
6
Plantar fibromatosis: Surgical approach of a giant bilateral case. ( 29265359 )
2018
7
Expression of CD163 in hereditary gingival fibromatosis: A possible association with TGF-I^1. ( 29325232 )
2018
8
Gene expression profiling and bioinformatics analysis of hereditary gingival fibromatosis. ( 29435271 )
2018
9
A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature. ( 29881291 )
2018
10
Successful Management of Aggressive Fibromatosis of the Neck: A Case Report ( 29843498 )
2018
11
Hyaline fibromatosis syndrome (juvenile hyaline fibromatosis): whole-body MR findings in two siblings with different subcutaneous nodules distribution. ( 29058046 )
2018
12
Marginal versus segmental mandibulectomy for pediatric desmoid fibromatosis of the mandible - Two case reports and review of the literature. ( 29728178 )
2018
13
Sporadic Abdominal Wall Desmoid type Fibromatosis: treatment paradigm after thirty two years. ( 29879959 )
2018
14
Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response. ( 29785261 )
2018
15
Infantile digital fibromatosis-like tumor of adult. ( 29319280 )
2018
16
Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis. ( 29901254 )
2018
17
Plantar Fibromatosis: Pathophysiology, Surgical and Nonsurgical Therapies: An Evidence-Based Review. ( 29310463 )
2018
18
Orbital Desmoid-Type Fibromatosis: A Case Report and Literature Review. ( 29707396 )
2018
19
The Use of Cryotherapy to Treat Infantile Digital Fibromatosis with a Functional Deficit: A Case Report. ( 29734898 )
2018
20
Aggressive breast fibromatosis following augmentation mastoplasty: a series of case reports. ( 29910830 )
2018
21
The genetic basis of hyaline fibromatosis syndrome in patients from a consanguineous background: a case series. ( 29801470 )
2018
22
An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature. ( 29751773 )
2018
23
Sporadic Desmoid-Type Fibromatosis Occurring at Laparoscopic Trocar Site: An Unusual Entity. ( 29973760 )
2018
24
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis. ( 29368261 )
2018
25
Radiation Therapy as an Alternative Treatment for Desmoid Fibromatosis. ( 29803344 )
2018
26
Mesenteric fibromatosis: a rare cause of peritonitis. ( 29424348 )
2018
27
Erosive Arthritis, Fibromatosis, and Keloids: A Rare Dermatoarthropathy. ( 29850357 )
2018
28
Sternocleidomastoid tumour in neonate:<i>fibromatosis colli</i>. ( 29326344 )
2018
29
Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis. ( 29170886 )
2018
30
An Algorithmic Approach to the Management of Infantile Digital Fibromatosis: Review of Literature and a Case Report. ( 29780440 )
2018
31
Aggressive desmoid fibromatosis of the neck after total thyroidectomy. ( 29940677 )
2018
32
Duodenum-derived fibromatosis that invaded the muscular layer of intestinal wall: A rare case report. ( 28767596 )
2017
33
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor. ( 28578783 )
2017
34
Plantar Fascial Fibromatosis: Two Cases Treated With Low-Energy Focused Shock Waves. ( 28002162 )
2017
35
Effect of surgical margins on prognosis in aggressive fibromatosis: A single-institutional analysis of 90 patients. ( 29113152 )
2017
36
TGF-I^ and CTGF are Mitogenic Output Mediators of Wnt/I^-Catenin Signaling in Desmoid Fibromatosis. ( 26894649 )
2017
37
Plantar Fibromatosis in a Mentally Challenged Man Treated with Intralesional Corticosteroids. ( 29282193 )
2017
38
Juvenile Hyaline Fibromatosis- A Rare Autosomal Recessive Disease. ( 28892992 )
2017
39
Fibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy. ( 28821190 )
2017
40
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. ( 28735069 )
2017
41
Squamous cell carcinoma arising in familial gingival fibromatosis-a rare case report. ( 29026519 )
2017
42
CMG2/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome. ( 28604699 )
2017
43
Hereditary gingival fibromatosis: Characteristics and treatment approach. ( 28469831 )
2017
44
Unusual presentation of familial gingival fibromatosis among male siblings. ( 29398861 )
2017
45
Gingival fibromatosis with hypertrichosis syndrome: Case series of rare syndrome. ( 28836540 )
2017
46
Effective Treatment of Aggressive Fibromatosis with Celecoxib Guided by Genetic testing. ( 28881160 )
2017
47
Local recurrence of sporadic mesenteric fibromatosis following radical surgery attacking the proximal jejunum. ( 29123587 )
2017
48
Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases. ( 28794344 )
2017
49
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor. ( 28887726 )
2017
50
Multiple Recurrent Fibromatosis With Cranial Fasciitis Characteristics in a Pediatric Patient. ( 28885439 )
2017

Variations for Fibromatosis

Expression for Fibromatosis

Search GEO for disease gene expression data for Fibromatosis.

Pathways for Fibromatosis

Pathways related to Fibromatosis according to GeneCards Suite gene sharing:

(show all 19)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.96 APC CTNNB1 KIT SOS1 VIM
2
Show member pathways
12.7 APC CTNNB1 KIT SOS1
3
Show member pathways
12.59 APC CTNNB1 KIT SOS1
4 12.55 APC CTNNB1 KIT SOS1
5
Show member pathways
12.42 APC CTNNB1 KIT SOS1
6 11.89 APC CTNNB1 SOS1
7 11.75 APC CTNNB1 REST
8
Show member pathways
11.61 APC CTNNB1 VIM
9 11.56 APC CTNNB1 SOS1
10 11.48 APC CTNNB1 SOS1
11
Show member pathways
11.39 APC CTNNB1 REST VIM
12 11.19 ACTC1 CTNNB1
13 11.07 CTNNB1 VIM
14 11.03 APC CTNNB1
15 10.99 ACTC1 DES VIM
16 10.92 APC CTNNB1
17 10.73 APC CTNNB1
18 10.63 APC CTNNB1 SOS1
19 10.61 KIT SOS1

GO Terms for Fibromatosis

Cellular components related to Fibromatosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoskeleton GO:0005856 9.8 ACTC1 APC CTNNB1 DES VIM
2 lamellipodium GO:0030027 9.5 ACTC1 APC CTNNB1
3 cell-cell junction GO:0005911 9.43 CTNNB1 DES KIT
4 catenin complex GO:0016342 9.37 APC CTNNB1
5 beta-catenin destruction complex GO:0030877 9.16 APC CTNNB1
6 Wnt signalosome GO:1990909 8.96 APC CTNNB1
7 fascia adherens GO:0005916 8.62 CTNNB1 DES
8 cytosol GO:0005829 10.03 ACTC1 APC CTNNB1 DES REST SAMD9

Biological processes related to Fibromatosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.56 ACTC1 CTNNB1 KIT VIM
2 T cell differentiation GO:0030217 9.46 CTNNB1 KIT
3 positive regulation of apoptotic process GO:0043065 9.46 APC CTNNB1 REST SOS1
4 beta-catenin destruction complex disassembly GO:1904886 9.43 APC CTNNB1
5 cell fate specification GO:0001708 9.4 APC CTNNB1
6 intermediate filament organization GO:0045109 9.37 DES VIM
7 positive regulation of pseudopodium assembly GO:0031274 9.32 APC KIT
8 regulation of T cell proliferation GO:0042129 8.96 CTNNB1 SOS1
9 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Sources for Fibromatosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....